Lion Point Capital, LP

NEW YORK, NY · CIK 1643354 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2015 · limited partnership

Assets managed$480.6m
Staff7 · 2 in investment roles
Main clients (by assets)Private funds 100%
Private funds5 (2 hedge) · $480.5m gross assets
Websitelionpoint.com
Form ADV · 2026-04-30SEC adviser record

Legal entityLION POINT CAPITAL, LP (US)

Kindhedge funds, private equity, futures
Others nearbyNew York, NY

As an employer

Offices in1 country
Private fundshedge 2, private equity 3

$20.9m reported value +24.9% vs Q1 2026

35positions

55.0%in top 10

1 new 0 added 0 reduced 1 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change
1	CUE BIOPHARMA INC COM CUE	CUE	52,928	$1.7m7.99%	7.99%	New
2	PRAXIS PRECISION MEDICINES I COM NEW PRAX	PRAX	4,450	$1.5m7.13%	7.13%	Unchanged
3	MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX	MLTX	67,500	$1.3m6.29%	6.29%	Unchanged
4	FENNEC PHARMACEUTICALS INC COM FENC	FENC	112,434	$1.2m5.78%	5.78%	Unchanged
5	ROYALTY PHARMA PLC SHS CLASS A RPRX	RPRX	21,400	$1.2m5.74%	5.74%	Unchanged
6	COMPASS PATHWAYS PLC SPONSORED ADS CMPS	CMPS	80,000	$1.1m5.41%	5.41%	Unchanged
7	MILESTONE PHARMACEUTICALS IN COM MIST	MIST	820,000	$1.1m5.26%	5.26%	Unchanged
8	BENITEC BIOPHARMA INC COM NEW BNTC	BNTC	62,000	$829.6k3.97%	3.97%	Unchanged
9	SYNDAX PHARMACEUTICALS INC COM SNDX	SNDX	36,000	$787.0k3.76%	3.76%	Unchanged
10	BIOHAVEN LTD COM BHVN	BHVN	51,700	$769.3k3.68%	3.68%	Unchanged
11	GERON CORP COM GERN	GERN	578,000	$739.8k3.54%	3.54%	Unchanged
12	UNIQURE NV SHS QURE	QURE	14,700	$677.1k3.24%	3.24%	Unchanged
13	ARDELYX INC COM ARDX	ARDX	128,650	$656.1k3.14%	3.14%	Unchanged
14	LANTHEUS HLDGS INC COM LNTH	LNTH	5,500	$610.2k2.92%	2.92%	Unchanged
15	DISC MEDICINE INC COM IRON	IRON	8,100	$592.4k2.83%	2.83%	Unchanged
16	SAREPTA THERAPEUTICS INC COM SRPT	SRPT	28,500	$512.1k2.45%	2.45%	Unchanged
17	HUMACYTE INC COM HUMA	HUMA	650,000	$507.3k2.43%	2.43%	Unchanged
18	KURA ONCOLOGY INC COM KURA	KURA	46,000	$504.6k2.41%	2.41%	Unchanged
19	VIATRIS INC COM VTRS	VTRS	27,700	$439.9k2.10%	2.10%	Unchanged
20	DYNE THERAPEUTICS INC COM DYN	DYN	18,000	$399.8k1.91%	1.91%	Unchanged
21	BRIDGEBIO PHARMA INC COM BBIO	BBIO	5,000	$372.4k1.78%	1.78%	Unchanged
22	EDGEWISE THERAPEUTICS INC COM EWTX	EWTX	9,100	$369.7k1.77%	1.77%	Unchanged
23	PACIRA BIOSCIENCES INC COM PCRX	PCRX	13,500	$342.5k1.64%	1.64%	Unchanged
24	REGENXBIO INC COM RGNX	RGNX	26,600	$318.7k1.52%	1.52%	Unchanged
25	ROCKET PHARMACEUTICALS INC COM RCKT	RCKT	86,000	$294.1k1.41%	1.41%	Unchanged
26	JANUX THERAPEUTICS INC COM JANX	JANX	19,000	$291.8k1.40%	1.40%	Unchanged
27	MINERALYS THERAPEUTICS INC COM MLYS	MLYS	10,500	$283.3k1.36%	1.36%	Unchanged
28	GH RESEARCH PLC ORDINARY SHARES GHRS	GHRS	10,200	$274.2k1.31%	1.31%	Unchanged
29	SERES THERAPEUTICS INC COM NEW MCRB	MCRB	31,570	$249.1k1.19%	1.19%	Unchanged
30	AZENTA INC COM AZTA	AZTA	9,700	$247.5k1.18%	1.18%	Unchanged
31	JASPER THERAPEUTICS INC COM NEW JSPR	JSPR	465,000	$195.8k0.94%	0.94%	Unchanged
32	INNOVIVA INC COM INVA	INVA	8,200	$186.2k0.89%	0.89%	Unchanged
33	INNATE PHARMA S A SPONSORED ADS IPHA	IPHA	81,151	$149.3k0.71%	0.71%	Unchanged
34	ARCUTIS BIOTHERAPEUTICS INC COM ARQT	ARQT	5,250	$137.7k0.66%	0.66%	Unchanged
35	SPRUCE BIOSCIENCES INC COM NEW SPRB	SPRB	1,000	$54.0k0.26%	0.26%	Unchanged

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
CUE BIOPHARMA INC		2,202,854	$506.4k2.2m shares